TP Therapeutics logo

TP Therapeutics Funding & Investors

Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves medical sector in the United States.

tptherapeutics.com

Total Amount Raised: $125,000,000

TP Therapeutics Funding Rounds

  • Private Equity

    $80,000,000

    Private Equity Investors

    Foresite Capital
    venBio Partners
    HBM Healthcare Investments
    Sr One
    Nextech Invest
    Cormorant Asset Management
    Lilly Asia Ventures
    Kenson Ventures
    OrbiMed
  • Series C

    $45,000,000

    Series C Investors

    Lilly Asia Ventures
    OrbiMed
    Sr One
    Cormorant Asset Management
    SV Tech Ventures
Funding info provided by Diffbot.